Pacific Biosciences Of California reported $307.85M in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Agilent USD 4.69B 70M Jun/2026
Bruker USD 2.16B 67.9M Sep/2026
Danaher USD 14.79B 1.41B Sep/2026
General Electric Aerospace USD 41.53B 1.83B Sep/2026
Illumina USD 3.04B 201M Sep/2026
Myriad Genetics USD 289M 23.8M Jun/2026
Pacific Biosciences Of California USD 307.85M 30.78M Sep/2026
Quidel USD 1.45B 69.4M Sep/2026
Revvity USD 1.86B 436.33M Sep/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Standard Biotools USD 497.3M 19.56M Sep/2026
Thermo Fisher Scientific USD 25.62B 2.25B Sep/2026
Waters USD 3.9B 186M Jun/2026